In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

BioNano nets $19mm through Nasdaq IPO

Executive Summary

Life sciences instrumentation company BioNano Genomics Inc. (genome mapping systems) netted $19mm in its initial public offering of 3.36mm units at $6.125. Each unit consists of one share of common stock and one warrant to purchase one common share at an exercise price of $6.125. Last month, the company announced it first planned to offer 3.35mm shares between $8-10, but later revised that range to $5-6 for 5.5mm shares, and again updated the offering to a proposed 2.45mm units at a $6-7 price.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Nanotechnology, Chips, etc.
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies